• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经阈下微脉冲激光治疗的慢性中心性浆液性脉络膜视网膜病变患者的功能和形态学转归

Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.

作者信息

Gawęcki Maciej, Jaszczuk-Maciejewska Agnieszka, Jurska-Jaśko Anna, Grzybowski Andrzej

机构信息

Dobry Wzrok Ophthalmological Clinic, Kliniczna 1B/2, 80-402, Gdańsk, Poland.

Chair of Ophthalmology, University of Warmia and Mazury, Warszawska 30, 10-082, Olsztyn, Poland.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2299-2306. doi: 10.1007/s00417-017-3783-x. Epub 2017 Aug 22.

DOI:10.1007/s00417-017-3783-x
PMID:28831603
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5696495/
Abstract

BACKGROUND

Chronic central serous chorioretinopathy is a serious therapeutic problem as it may lead to significant visual impairment. The aim of this retrospective study is to evaluate functional and morphological effects, as well as factors influencing visual outcome in patients treated by subthreshold micropulse laser.

METHODS

Fifty-one eyes with chronic central serous chorioretinopathy lasting longer than 4 months (18 months on average) underwent up to two sessions of subtreshold micropulse laser treatment. Change in best corrected visual acuity, central retinal thickness, central retinal volume, average central retinal thickness and maximum subretinal fluid height were measured. Relation between the effects of the treatment and the initial retinal morphological and functional parameters was then analyzed.

RESULTS

The total resorption of subretinal fluid was achieved in 36 cases (70.6%). There was, however, only a minor improvement in best corrected visual acuity of approximately one line on the Snellen chart. No correlation was observed between the effects of the treatment and the duration of the symptoms, retinal morphology and initial visual acuity. Younger patients responded better to the therapy.

CONCLUSION

Subthreshold micropulse laser treatment in chronic serous chorioretinopathy provides good morphological results, however significant improvement of visual acuity is not to be expected.

摘要

背景

慢性中心性浆液性脉络膜视网膜病变是一个严重的治疗难题,因为它可能导致明显的视力损害。这项回顾性研究的目的是评估阈下微脉冲激光治疗患者的功能和形态学效果,以及影响视力预后的因素。

方法

51只患有慢性中心性浆液性脉络膜视网膜病变且病程超过4个月(平均18个月)的眼睛接受了最多两次阈下微脉冲激光治疗。测量最佳矫正视力、中心视网膜厚度、中心视网膜体积、平均中心视网膜厚度和最大视网膜下液高度的变化。然后分析治疗效果与初始视网膜形态和功能参数之间的关系。

结果

36例(70.6%)实现了视网膜下液的完全吸收。然而,最佳矫正视力仅在Snellen视力表上有大约一行的轻微改善。未观察到治疗效果与症状持续时间、视网膜形态和初始视力之间的相关性。年轻患者对治疗反应更好。

结论

慢性浆液性脉络膜视网膜病变的阈下微脉冲激光治疗可提供良好的形态学结果,但视力的显著改善难以预期。

相似文献

1
Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.经阈下微脉冲激光治疗的慢性中心性浆液性脉络膜视网膜病变患者的功能和形态学转归
Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2299-2306. doi: 10.1007/s00417-017-3783-x. Epub 2017 Aug 22.
2
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变消退后的视力和视网膜形态损害
BMC Ophthalmol. 2019 Jul 25;19(1):160. doi: 10.1186/s12886-019-1171-5.
3
Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.慢性中心性浆液性脉络膜视网膜病变中的阈下微脉冲黄色激光(577纳米):安全性和治疗效果
Eye (Lond). 2015 Feb;29(2):258-64; quiz 265. doi: 10.1038/eye.2014.315. Epub 2015 Jan 23.
4
Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.阈下微脉冲黄光激光(577纳米)光凝治疗慢性中心性浆液性脉络膜视网膜病变的短期疗效
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2129-35. doi: 10.1007/s00417-015-2965-7. Epub 2015 Feb 26.
5
Low-intensity/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy.低强度/高密度阈下微脉冲二极管激光治疗慢性中心性浆液性脉络膜视网膜病变
Retina. 2015 Mar;35(3):532-6. doi: 10.1097/IAE.0000000000000285.
6
BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.基线光谱域光学相干断层扫描高反射灶作为中心性浆液性脉络膜视网膜病变视觉预后和复发的预测指标
Retina. 2016 Jul;36(7):1372-80. doi: 10.1097/IAE.0000000000000929.
7
LOW-INTENSITY/HIGH-DENSITY SUBTHRESHOLD DIODE MICROPULSE LASER FOR CENTRAL SEROUS CHORIORETINOPATHY.用于中心性浆液性脉络膜视网膜病变的低强度/高密度阈下二极管微脉冲激光
Retina. 2016 Sep;36(9):1658-63. doi: 10.1097/IAE.0000000000001005.
8
The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy.阈下微脉冲黄色激光(577nm)治疗慢性中心性浆液性脉络膜视网膜病变的疗效。
Lasers Med Sci. 2021 Jul;36(5):981-988. doi: 10.1007/s10103-020-03129-5. Epub 2020 Aug 19.
9
COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.使用半剂量维替泊芬或半光通量激光进行光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的比较
Retina. 2017 Feb;37(2):325-333. doi: 10.1097/IAE.0000000000001138.
10
Comparing Half-Dose Photodynamic Therapy with Subthreshold Micropulse Laser for the Treatment of Central Serous Chorioretinopathy.比较半剂量光动力疗法与阈下微脉冲激光治疗中心性浆液性脉络膜视网膜病变。
Ophthalmol Retina. 2024 May;8(5):490-498. doi: 10.1016/j.oret.2023.10.024. Epub 2023 Nov 11.

引用本文的文献

1
Subthreshold Micropulse Laser (577 nm) Therapy with an Individual Approach for Power Titration in Patients with Chronic Central Serous Chorioretinopathy (Pilot Study).慢性中心性浆液性脉络膜视网膜病变患者采用个体化功率滴定的阈下微脉冲激光(577nm)治疗(初步研究)
J Ophthalmol. 2024 Oct 8;2024:9750395. doi: 10.1155/2024/9750395. eCollection 2024.
2
Settings and Clinical Applications of Subthreshold Micropulse Laser Therapy: A Review.阈下微脉冲激光治疗的设置与临床应用:综述
J Clin Med. 2024 Sep 26;13(19):5729. doi: 10.3390/jcm13195729.
3
Crossover to PDT after the unsuccessful micropulse laser treatment of central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变微脉冲激光治疗失败后交叉接受光动力疗法。
Adv Ophthalmol Pract Res. 2024 Jan 23;4(1):32-38. doi: 10.1016/j.aopr.2024.01.004. eCollection 2024 Feb-Mar.
4
Subthreshold laser treatment in retinal diseases: a mini review.亚阈激光治疗视网膜疾病:小型综述。
Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2337-2344. doi: 10.1007/s00417-024-06382-4. Epub 2024 Jan 27.
5
Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathy.半剂量光动力疗法与 577nm 亚阈脉冲激光治疗初治中心性浆液性脉络膜视网膜病变的比较。
BMC Ophthalmol. 2024 Jan 4;24(1):8. doi: 10.1186/s12886-023-03274-9.
6
The effect of nondamaging subthreshold laser therapy in patients with chronic central serous chorioretinopathy.非损伤性亚阈值激光疗法对慢性中心性浆液性脉络膜视网膜病变患者的疗效。
Graefes Arch Clin Exp Ophthalmol. 2024 May;262(5):1433-1442. doi: 10.1007/s00417-023-06315-7. Epub 2023 Nov 27.
7
Micropulse Laser Therapy as an Integral Part of Eye Disease Management.微脉冲激光治疗作为眼病管理的一个组成部分。
Medicina (Kaunas). 2023 Jul 28;59(8):1388. doi: 10.3390/medicina59081388.
8
Efficacy and safety of subthreshold micropulse laser in the treatment of acute central serous chorioretinopathy.阈下微脉冲激光治疗急性中心性浆液性脉络膜视网膜病变的疗效与安全性
Int J Ophthalmol. 2023 Jun 18;16(6):921-927. doi: 10.18240/ijo.2023.06.14. eCollection 2023.
9
Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature.黄色阈下微脉冲激光治疗视网膜疾病:文献的深入分析与综述
Ophthalmol Ther. 2023 Jun;12(3):1479-1500. doi: 10.1007/s40123-023-00698-w. Epub 2023 Mar 18.
10
Significant Visual Impairment after Short-Lasting Central Serous Chorioretinopathy.短期中心性浆液性脉络膜视网膜病变后的严重视力损害。
Case Rep Ophthalmol. 2022 Sep 19;13(3):678-685. doi: 10.1159/000525924. eCollection 2022 Fall.

本文引用的文献

1
Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.韩国患者慢性中心性浆液性脉络膜视网膜病变的自动实时反馈控制剂量测定选择性视网膜治疗。
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1375-1383. doi: 10.1007/s00417-017-3672-3. Epub 2017 Apr 18.
2
Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy.半剂量光动力疗法与689纳米激光治疗慢性中心性浆液性脉络膜视网膜病变的疗效比较
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1141-1148. doi: 10.1007/s00417-017-3626-9. Epub 2017 Mar 10.
3
Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy.低能量光动力疗法与阈下微脉冲黄光波长激光治疗慢性中心性浆液性脉络膜视网膜病变的比较
J Ophthalmol. 2016;2016:3513794. doi: 10.1155/2016/3513794. Epub 2016 Aug 15.
4
Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者亚阈值微脉冲激光(577nm)治疗与半剂量光动力疗法的比较
Eye (Lond). 2016 Oct;30(10):1371-1377. doi: 10.1038/eye.2016.142. Epub 2016 Jul 8.
5
LOW-INTENSITY/HIGH-DENSITY SUBTHRESHOLD DIODE MICROPULSE LASER FOR CENTRAL SEROUS CHORIORETINOPATHY.用于中心性浆液性脉络膜视网膜病变的低强度/高密度阈下二极管微脉冲激光
Retina. 2016 Sep;36(9):1658-63. doi: 10.1097/IAE.0000000000001005.
6
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy.玻璃体内注射贝伐单抗治疗中心性浆液性脉络膜视网膜病变
J Ophthalmic Vis Res. 2016 Jan-Mar;11(1):61-5. doi: 10.4103/2008-322X.180700.
7
Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy: A Comparative Analysis.盐皮质激素拮抗剂治疗中心性浆液性脉络膜视网膜病变的比较分析
Ophthalmic Res. 2016;56(1):17-22. doi: 10.1159/000444058. Epub 2016 Mar 17.
8
Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.口服盐皮质激素受体拮抗剂:非消退性慢性上皮病变性中心性浆液性脉络膜视网膜病变临床亚型的真实生活经验
Transl Vis Sci Technol. 2016 Mar 4;5(2):2. doi: 10.1167/tvst.5.2.2. eCollection 2016 Mar.
9
Subthreshold Diode Micropulse Laser: A Review.亚阈值二极管微脉冲激光:综述
Semin Ophthalmol. 2016;31(1-2):30-9. doi: 10.3109/08820538.2015.1114837.
10
RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis.中心性浆液性脉络膜视网膜病变的危险因素:一项系统评价与Meta分析
Retina. 2016 Jan;36(1):9-19. doi: 10.1097/IAE.0000000000000837.